Skip to main content
. Author manuscript; available in PMC: 2015 Jun 3.
Published in final edited form as: J Cardiovasc Pharmacol. 2009 Oct;54(4):279–286. doi: 10.1097/FJC.0b013e3181a1b9e7

Table 1.

Clinically relevant “causes” of late INa and possible mechanisms. Remodeling means alteration of the Na channel complex in a way that favors late INa by for example the disappearance of subunits [49]. References for these clinically relevant, and many other experimentally relevant causes of late INa have been recently reviewed [7]

Genetic
   LQT3 Direct Biophysical
   LQT9 Enhanced Nitrosylation
   LQT10    ?
   LQT12 Enhanced Nitrosylation
Acquired
   Hypertrophy Stretch, altered signaling, remodeling
   Heart Failure Stretch, altered signaling, remodeling
   Ischemia Acidosis, metabolites (LPC)
   Diabetes Cardiomyopathy, altered signaling
Molecules
   Carbon Monoxide    ?
   Acidosis    ?
   LPC (ischemic metabolite)    PKC?
   ROS (H2O2)    CamK?
Drugs
   Dofetilide    PI3K inhibition
   Sotalol    PI3K inhibition
   Erythromycin    PI3K inhibition
   Thioridazine    PI3K inhibition
   Nilotinib    PI3K inhibition
Cell signaling
   nNOS Nitrosylation    direct on NaV1.5
   CamK Phosphorylation    direct on NaV1.5
   PI3K-Akt pathway inhibition    ?
   PKC Phosphorylation    direct on NaV1.5